• To enhance your knowledge of the use of sodium glucose co-transporter 2 (SGLT2) inhibitors in the management of type 2 diabetes
• To be aware of the benefits and side effects of SGLT2 inhibitors
• To understand the role of nurses in ensuring that SGLT2 inhibitors are used safely and appropriately
One class of oral medicines used in the management of type 2 diabetes is sodium glucose co-transporter 2 (SGLT2) inhibitors. Their mode of action is unique and is not dependent on beta-cell function or the degree of a person’s insulin resistance. This article reviews the use of SGLT2 inhibitors in managing type 2 diabetes, explaining the potential benefits and side effects of these medicines. It also explains the role of healthcare professionals, including nurses, in ensuring these medicines are used safely and appropriately.
Nursing Standard. doi: 10.7748/ns.2022.e11959
Peer reviewThis article has been subject to external double-blind peer review and checked for plagiarism using automated software
Correspondence Conflict of interestNone declared
Noble-Bell G, Bright-Davies C (2022) Safe use of sodium glucose co-transporter 2 inhibitors in the management of type 2 diabetes. Nursing Standard. doi: 10.7748/ns.2022.e11959
Published online: 07 November 2022
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
